Masakatsu Eguchi

Masakatsu Eguchi

Auto-generated profile, based on publicly available information

Masakatsu Eguchi

Department of Pharmaceutics, University of Washington, Seattle, Washington, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2025 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
LDLuqi Duan
Luqi Duan
SDShreshtha Dash
Shreshtha Dash
MEMasa Eguchi
Masa Eguchi
RFRachele Delle Fratte
Rachele Delle Fratte
ZSZachary R Stephen
Zachary R Stephen
RHRodney Jy Ho
Rodney Jy Ho

4 May 2023 in Journal of Analytical & Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
MEMasakatsu Eguchi
Masakatsu Eguchi
This minireview summarized a part of the recent work of Professor Mauro Ferrari on the application of mesoporous silicon microparticles to celebrate the occasion of the establishment of a new company, BrYet Pharma. This article is focusing on the principle and application of injectable nanoparticle generators (iNPG) for drug delivery systems. Three main examples are described; deliveries of anti-cancer agents and peptide cancer vaccines using iNPG, and oral formulation of iNPG for inflamed intestinal mucosa. The iNPG drug delivery system provides protection, the versatility of loading, and the selective delivery of therapeutics, which enables prolonged efficacy, the simultaneous delivery of a combination of therapeutics, and the reduction of toxicity. The advantages of the iNPG drug delivery system are discussed with examples in this minireview.